Literature DB >> 16407308

Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis.

Barbara Balestrieri1, Victor W Hsu, Huiya Gilbert, Christina C Leslie, Won K Han, Joseph V Bonventre, Jonathan P Arm.   

Abstract

We have previously reported that group V secretory phospholipase A2 (sPLA2) amplifies the action of cytosolic phospholipase A2(cPLA2) alpha in regulating eicosanoid biosynthesis by mouse peritoneal macrophages stimulated with zymosan (Satake, Y., Diaz, B. L., Balestrieri, B., Lam, B. K., Kanaoka, Y., Grusby, M. J., and Arm, J. P. (2004) J. Biol. Chem. 279, 16488-16494). To further understand the role of group V sPLA2, we studied its localization in resting mouse peritoneal macrophages before and after stimulation with zymosan and the effect of deletion of the gene encoding group V sPLA2 on phagocytosis of zymosan. We report that group V sPLA2 is present in the Golgi apparatus and recycling endosome in the juxtanuclear region of resting peritoneal macrophages. Upon ingestion of zymosan by mouse peritoneal macrophages, group V sPLA2 is recruited to the phagosome. There it co-localizes with cPLA2alpha, 5-lipoxygenase, 5-lipoxygenase-activating protein, and leukotriene C4 synthase. Using immunostaining for the cysteinyl leukotrienes in carbodiimide-fixed cells, we show, for the first time, that the phagosome is a site of cysteinyl leukotriene formation. Furthermore, peritoneal macrophages from group V sPLA2-null mice demonstrated a >50% attenuation in phagocytosis of zymosan particles, which was restored by adenoviral expression of group V sPLA2 but IIA not group sPLA2. These data demonstrate that group V sPLA2 contributes to the innate immune response both through regulation of eicosanoid generation in response to a phagocytic stimulus and also as a component of the phagocytic machinery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407308      PMCID: PMC1820836          DOI: 10.1074/jbc.M508314200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Cloning and recombinant expression of a novel mouse-secreted phospholipase A2.

Authors:  E Valentin; R S Koduri; J C Scimeca; G Carle; M H Gelb; M Lazdunski; G Lambeau
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

2.  Low molecular weight group IIA and group V phospholipase A(2) enzymes have different intracellular locations in mouse bone marrow-derived mast cells.

Authors:  C O Bingham; R J Fijneman; D S Friend; R P Goddeau; R A Rogers; K F Austen; J P Arm
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

3.  Regulation of delayed prostaglandin production in activated P388D1 macrophages by group IV cytosolic and group V secretory phospholipase A2s.

Authors:  H Shinohara; M A Balboa; C A Johnson; J Balsinde; E A Dennis
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

4.  On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes.

Authors:  E Valentin; F Ghomashchi; M H Gelb; M Lazdunski; G Lambeau
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

5.  NADPH oxidase activation and assembly during phagocytosis.

Authors:  F R DeLeo; L A Allen; M Apicella; W M Nauseef
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

6.  Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2.

Authors:  R T Pickard; B A Strifler; R M Kramer; J D Sharp
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

7.  Identification of a third pathway for arachidonic acid mobilization and prostaglandin production in activated P388D1 macrophage-like cells.

Authors:  J Balsinde; M A Balboa; E A Dennis
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

8.  Cytosolic phospholipase A2 is required for macrophage arachidonic acid release by agonists that Do and Do not mobilize calcium. Novel role of mitogen-activated protein kinase pathways in cytosolic phospholipase A2 regulation.

Authors:  M A Gijón; D M Spencer; A R Siddiqi; J V Bonventre; C C Leslie
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

9.  5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae.

Authors:  P Mancuso; T J Standiford; T Marshall; M Peters-Golden
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2.

Authors:  J Balsinde; M A Balboa; E A Dennis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more
  49 in total

1.  Anti-inflammatory effect of acetylpuerarin on eicosanoid signaling pathway in primary rat astrocytes.

Authors:  Yanxiao Xiang; Xinbing Wei; Lin Chen; Huiqing Liu; Xiaoqian Liu; Tian Wang; Xiumei Zhang
Journal:  J Mol Neurosci       Date:  2013-09-13       Impact factor: 3.444

2.  Co-operative signalling through DP(1) and DP(2) prostanoid receptors is required to enhance leukotriene C(4) synthesis induced by prostaglandin D(2) in eosinophils.

Authors:  F P Mesquita-Santos; I Bakker-Abreu; T Luna-Gomes; P T Bozza; B L Diaz; C Bandeira-Melo
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

3.  Group V secretory phospholipase A2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation.

Authors:  Shin Ohta; Mitsuru Imamura; Wei Xing; Joshua A Boyce; Barbara Balestrieri
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

4.  Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.

Authors:  Hiroyasu Sato; Rina Kato; Yuki Isogai; Go-ichi Saka; Mitsuhiro Ohtsuki; Yoshitaka Taketomi; Kei Yamamoto; Kae Tsutsumi; Joe Yamada; Seiko Masuda; Yukio Ishikawa; Toshiharu Ishii; Tetsuyuki Kobayashi; Kazutaka Ikeda; Ryo Taguchi; Shinji Hatakeyama; Shuntaro Hara; Ichiro Kudo; Hiroyuki Itabe; Makoto Murakami
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

Review 5.  Identifying intracellular sites of eicosanoid lipid mediator synthesis with EicosaCell assays.

Authors:  Christianne Bandeira-Melo; Peter F Weller; Patricia T Bozza
Journal:  Methods Mol Biol       Date:  2011

Review 6.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

Review 7.  Exosomal miRNAs: novel players in viral infection.

Authors:  Javid Sadri Nahand; Maryam Mahjoubin-Tehran; Mohsen Moghoofei; Mohammad Hossein Pourhanifeh; Hamid Reza Mirzaei; Zatollah Asemi; Alireza Khatami; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Epigenomics       Date:  2020-02-25       Impact factor: 4.778

8.  Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammation.

Authors:  Hiroyasu Sato; Yoshitaka Taketomi; Yuki Isogai; Seiko Masuda; Tetsuyuki Kobayashi; Kei Yamamoto; Makoto Murakami
Journal:  Biochem J       Date:  2009-06-12       Impact factor: 3.857

Review 9.  Eicosanoids in the innate immune response: TLR and non-TLR routes.

Authors:  Yolanda Alvarez; Isela Valera; Cristina Municio; Etzel Hugo; Francisco Padrón; Lydia Blanco; Mario Rodríguez; Nieves Fernández; Mariano Sánchez Crespo
Journal:  Mediators Inflamm       Date:  2010-06-15       Impact factor: 4.711

10.  Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice.

Authors:  Nilda M Muñoz; Angelo Y Meliton; Lucille N Meliton; Steven M Dudek; Alan R Leff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-13       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.